REGENERON PHARMACEUTICALS, INC. Operating Income 2008-2025 | REGN
What is operating income?
Operating income can be defined as profit from core business operations, calculated as gross profit minus operating expenses, before interest and taxes.
What is REGENERON PHARMACEUTICALS, INC.'s current operating income?
REGENERON PHARMACEUTICALS, INC. (REGN) annual operating income for 2025 was $3.58B, a 10.34% decline from 2024. REGENERON PHARMACEUTICALS, INC. operating income for the quarter ending December 31, 2025 was $879.9M.
What was REGENERON PHARMACEUTICALS, INC.'s operating income in 2024?
REGENERON PHARMACEUTICALS, INC. annual operating income for 2024 was $3.99B, a 1.39% decline from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s operating income in 2023?
REGENERON PHARMACEUTICALS, INC. annual operating income for 2023 was $4.05B, a 14.60% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year operating income CAGR?
REGENERON PHARMACEUTICALS, INC. operating income grew at a compound annual growth rate (CAGR) of 0.01% from FY2020 to FY2025, going from $3.58B to $3.58B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.58B | -10.3% | 10-K |
| FY2024 | $3.99B | -1.4% | 10-K |
| FY2023 | $4.05B | -14.6% | 10-K |
| FY2022 | $4.74B | -47.0% | 10-K |
| FY2021 | $8.95B | +150.1% | 10-K |
| FY2020 | $3.58B | +61.9% | 10-K |
| FY2019 | $2.21B | -12.8% | 10-K |
| FY2018 | $2.53B | +21.9% | 10-K |
| FY2017 | $2.08B | +56.3% | 10-K |
| FY2016 | $1.33B | +6.3% | 10-K |
| FY2015 | $1.25B | +51.9% | 10-K |
| FY2014 | $823.9M | +10.9% | 10-K |
| FY2013 | $743.0M | +62.3% | 10-K |
| FY2012 | $457.7M | +323.1% | 10-K |
| FY2011 | $-205.2M | -110.5% | 10-K |
| FY2010 | $-97.5M | -31.5% | 10-K |
| FY2009 | $-74.1M | +14.1% | 10-K |
| FY2008 | $-86.2M | - | 10-K |